Agency: Department of Health and Human Services (and, concurrently, Centers for Disease Control and Prevention) Role: Deputy Secretary of Health and Human Services (June 2025–February 2026); concurrently acting CDC director (August 2025–February 2026); nominated Director of the National Science Foundation (March 2, 2026), pending Severity: P2 — As acting CDC director, signed the January 5, 2026 decision memo revising the childhood immunization schedule without consulting ACIP, which a federal court stayed as contrary to law Party/Affiliation: Republican; technology investor; former managing director at Mithril Capital and CEO of the SENS Research Foundation

Basis for Inclusion

Subject classification: Public Official — Senate-confirmed appointee who served as acting head of a federal agency

Anchor: On January 5, 2026, O’Neill, as acting CDC director, signed the decision memorandum that cut the number of routinely recommended childhood vaccines, citing a presidential memorandum. On March 16, 2026, the U.S. District Court for the District of Massachusetts stayed that memo, holding it contrary to law because the director acted without consulting the Advisory Committee on Immunization Practices (ACIP), and arbitrary and capricious (American Academy of Pediatrics v. Kennedy, No. 1:25-cv-11916-BEM, Doc. 291). That ruling is the documented anchor; it is scored as institutional damage in Centers for Disease Control and Prevention — Agency Damage Assessment (D4, D8).

Democratic Malice Assessment

Designation: No formal DMA designation at this time

Ideology vs. Malice determination: Ideology / adjudicated procedural violation, without evidence of malicious intent. Changing vaccine recommendations is a policy choice an administration may pursue, inside the Ideology Safe Harbor, if it follows the process the law sets. O’Neill’s memo did not: the court found he bypassed ACIP’s statutory role and acted arbitrarily, and the order is on appeal. That is a documented, adjudicated procedural violation, not yet a finding of malice. The record does not show O’Neill orchestrated Susan Monarez’s removal, and the memo itself states it implemented a presidential memorandum and accepted recommendations presented by other officials. A DMA designation would need evidence of his own intent beyond carrying out a directive; that evidence is not in this record.

Framework disclosure: This assessment applies the published DMA framework’s Ideology vs. Malice Gate. It will be revisited when the First Circuit rules on the appeal (No. 26-1503) and if the multistate suit, State of Arizona v. Kennedy (N.D. Cal. 3:26-cv-01609), produces findings about the memo.

Legal Disclaimer

The Democratic Malice Assessment is an analytical framework applying defined criteria to documented public conduct. Designations are evaluative conclusions, not statements of criminal guilt. No DMS score constitutes a finding of criminal liability. The factual predicates are cited to primary sources; the evaluative conclusions are protected expression. New York Times Co. v. Sullivan and its progeny apply to this assessment of a public figure’s public conduct.

Bio and Background

James O’Neill served at HHS during the George W. Bush administration, rising to Principal Associate Deputy Secretary. He then worked as a technology investor, as a managing director at Peter Thiel’s Mithril Capital Management, and as CEO of the Thiel Foundation, per The Hill. From 2019 to 2021 he was CEO of the SENS Research Foundation, a longevity research nonprofit.[1][2][3] He had no prior medical or infectious-disease training; COSSA reported he had “a history of vaccine skepticism.”[4]

Documented Actions

Confirmation as Deputy Secretary

Action: The Senate confirmed O’Neill as Deputy Secretary of Health and Human Services on June 5, 2025, 52 to 43 (Record Vote 293). He was sworn in shortly after.[5][6]

Date: June 5, 2025

Evidence: Congress.gov nomination record and Holland & Knight’s summary.[5][6] Tier: Documented.

Acting CDC Director

Action: After Susan Monarez’s removal on August 27, 2025 (see Susan Monarez — Removed CDC Director), O’Neill was named acting CDC director while remaining deputy secretary.[2][4]

Date: August 2025 to February 13, 2026

Evidence: The Hill and COSSA.[2][4] Tier: Credibly reported.

The January 5, 2026 Schedule Memo

Action: CDC announced that “Deputy Secretary of Health and Human Services Jim O’Neill, in his role as Acting Director of the Centers for Disease Control and Prevention,” signed a decision memorandum accepting the recommendations of an assessment ordered by presidential memorandum and directing CDC to implement a revised childhood schedule. According to CDC’s release, he acted after reviewing a decision memo presented by NIH Director Jay Bhattacharya, FDA Commissioner Marty Makary and CMS Administrator Mehmet Oz. The revision removed universal recommendations for vaccines against rotavirus, meningococcal disease, hepatitis A, hepatitis B, influenza, COVID-19 and RSV.[7][8]

Date: January 5, 2026

Evidence: CDC press release, and the Maryland Attorney General’s description of the multistate complaint.[7][8] Tier: Documented.

The Court’s Stay

Action: On March 16, 2026, the District of Massachusetts stayed the January memo, holding it contrary to law (the director did not consult ACIP) and arbitrary and capricious, and also stayed the appointments of 13 ACIP members and all votes of the reconstituted committee. CDC restored the prior schedules to comply. The federal defendants appealed; the First Circuit expedited the appeal, and no merits ruling had issued as of October 14, 2026.[9][10]

Date: March 16, 2026 (order); appeal pending

Evidence: American Academy of Pediatrics v. Kennedy, D. Mass. 1:25-cv-11916-BEM, Doc. 291, as reproduced in the federal defendants’ First Circuit brief; CourtListener docket.[9][10] Tier: Documented.

Departure and NSF Nomination

Action: O’Neill left both HHS posts on February 13, 2026, in a leadership restructuring Reuters and STAT reported was meant to refocus HHS on politically popular parts of Kennedy’s agenda before the midterms. NIH Director Jay Bhattacharya became acting CDC director (see Jay Bhattacharya — NIH Director). On March 2, 2026, the President nominated O’Neill to be Director of the National Science Foundation for a six-year term; the nomination was referred to the HELP Committee. Science organizations including AAAS and the Coalition for National Science Funding later urged the committee to hold a hearing, and the Union of Concerned Scientists urged the Senate to reject him. No committee vote was found as of this profile’s date.[11][12][13][14][15]

Date: February–March 2026; nomination pending

Evidence: Reuters, STAT, Congress.gov (PN852-8) and the White House nominations list.[11][12][13][14] Tier: Documented as to the nomination.

Real-World Impact

• The schedule change and its reversal. For roughly ten weeks the official CDC childhood schedule omitted universal recommendations for seven vaccines. The court’s stay restored them, but the change was in force during the country’s worst measles year in decades (see Centers for Disease Control and Prevention — Agency Damage Assessment, D4 and D7).
• Litigation that outlived his tenure. Two federal suits — AAP v. Kennedy and the multistate State of Arizona v. Kennedy — challenge the memo he signed. His successor as director, Erica Schwartz, is a named defendant in the second (see Erica Schwartz — Director of the Centers for Disease Control and Prevention).

Truth and Reconciliation Considerations

• Directive versus discretion: The memo states it implemented a presidential memorandum. Whether O’Neill exercised independent judgment or carried out a decision made above him is not established in this record and matters to any individual accountability finding.
• Pending appeal: The district court granted preliminary relief, and it is under appeal. Its findings stand as findings while the appeal runs, but the merits remain open.

Key Connections

• Susan Monarez — The confirmed director he succeeded in an acting capacity. See Susan Monarez — Removed CDC Director.
• Jay Bhattacharya — Presented the schedule recommendation; succeeded him as acting CDC director. See Jay Bhattacharya — NIH Director.
• Erica Schwartz — Confirmed CDC director, August 2026. See Erica Schwartz — Director of the Centers for Disease Control and Prevention.
• Robert F. Kennedy Jr. — HHS Secretary. See Robert F. Kennedy Jr. — Political Accountability Profile.

Factual correction requests: If you believe information in this profile is incorrect, please contact factcheck@citizenanalyst.ai with your name (optional), the specific claim, and any supporting documentation. We review all submissions and correct verified errors promptly.

Sources

1. HHS, press release on O’Neill’s swearing-in as Deputy Secretary. https://www.hhs.gov/press-room/jim-oneill-sworn-in-as-deputy-secretary.html
2. The Hill, profile of O’Neill on his appointment as acting CDC director, August 2025. https://thehill.com/policy/healthcare/5478188-who-is-jim-oneill-trumps-new-cdc-director
3. MIT Technology Review, on O’Neill and the longevity movement, June 30, 2025. https://www.technologyreview.com/2025/06/30/1119449/hhs-robert-f-kennedy-jr-jim-oneill-longevity-maha
4. COSSA, “CDC Director Fired After Clash with HHS Secretary Kennedy Over Vaccines.” https://cossa.org/cdc-director-fired-after-clash-with-hhs-secretary-kennedy-over-vaccines/
5. Congress.gov, PN12-33, “James O’Neill, of California, to be Deputy Secretary of Health and Human Services,” confirmed 52–43, Record Vote 293. https://www.congress.gov/nomination/119th-congress/12/33
6. Holland & Knight, Health Dose, June 10, 2025. https://www.hklaw.com/en/insights/publications/2025/06/holland-knight-health-dose-june-10-2025
7. CDC, press release on the acting director’s childhood immunization schedule decision memorandum, January 5, 2026. https://www.cdc.gov/media/releases/2026/2026-cdc-acts-on-presidential-memorandum-to-update-childhood-immunization-schedule.html
8. Maryland Attorney General, “Attorney General Brown Joins Multistate Lawsuit Challenging the Kennedy Vaccine Schedule.” https://oag.maryland.gov/News/pages/Attorney-General-Brown-Joins-Multistate-Lawsuit-Challenging-the-Kennedy-Vaccine-Schedule-and-Unlawful-Overhaul-of-Federal-C.aspx
9. American Academy of Pediatrics v. Kennedy, D. Mass. 1:25-cv-11916-BEM, Doc. 291 (March 16, 2026), reproduced in the federal defendants’ First Circuit brief. https://www.courthousenews.com/wp-content/uploads/2026/10/vaccine-panel-stay-appellant-brief.pdf
10. CourtListener, American Academy of Pediatrics v. Kennedy docket. https://www.courtlistener.com/docket/70722326/american-academy-of-pediatrics-v-kennedy
11. Reuters, on O’Neill leaving his HHS posts, February 2026. https://www.reuters.com/business/healthcare-pharmaceuticals/top-hhs-officials-leave-their-posts-part-management-shakeup-politico-reports-2026-02-13/
12. STAT, “Leadership shakeup at RFK Jr.’s health department ahead of midterms,” February 13, 2026. https://www.statnews.com/2026/02/13/hhs-leadership-changes-rfk-jr-hhs-midterm-elections/
13. Congress.gov, PN852-8, “James O’Neill, of Texas, to be Director of the National Science Foundation,” received March 2, 2026. https://www.congress.gov/nomination/119th-congress/852/8
14. White House, Nominations Sent to the Senate, March 2026. https://www.whitehouse.gov/presidential-actions/2026/03/nominations-sent-to-the-senate-4e42
15. Union of Concerned Scientists, statement on O’Neill’s NSF nomination. https://www.ucs.org/about/news/nominee-lead-national-science-foundation-unacceptable-choice-senate-should-reject

Cross-References

• Centers for Disease Control and Prevention — Agency Damage Assessment — CDC Agency Damage Assessment
• Susan Monarez — Removed CDC Director, Erica Schwartz — Director of the Centers for Disease Control and Prevention, Jay Bhattacharya — NIH Director, Robert F. Kennedy Jr. — Political Accountability Profile